Terminated NA INTERVENTIONAL 1-arm NCT04839601

RNS System RESPONSE Study (RESPONSE)

RNS® System Responsive Stimulation for Adolescents With Epilepsy Study

Sponsor: NeuroPace

Conditions Drug Resistant Epilepsy Epilepsy Focal Epilepsy Neurostimulator; Complications Partial Seizure

Interventions RNS System

Updated 11 times since 2021 Last updated: May 19, 2025 Started: Oct 27, 2021 Primary completion: May 1, 2025 Completion: May 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Inadequate Enrollment

A NA clinical study on Drug Resistant Epilepsy and Epilepsy, this trial is terminated or withdrawn. The trial is conducted by NeuroPace and has accumulated 11 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

11 versions recorded

Jun 2025 — Present [monthly]

Terminated NA

Status: Recruiting → Terminated
Dec 2024 — Jun 2025 [monthly]

Recruiting NA
Sep 2024 — Dec 2024 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Mar 2024 — Jul 2024 [monthly]

Recruiting NA

▶ Show 6 earlier versions

Dec 2022 — Mar 2024 [monthly]

Recruiting NA
Sep 2022 — Dec 2022 [monthly]

Recruiting NA
May 2022 — Sep 2022 [monthly]

Recruiting NA

Phase: PHASE3 → NA
Jan 2022 — May 2022 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Sep 2021 — Jan 2022 [monthly]

Not Yet Recruiting PHASE3
May 2021 — Sep 2021 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NeuroPace

Data source: NeuroPace

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Grand Rapids, United States
• Hawthorne, United States